Mentice AB (publ) (STO:MNTC)

Market Cap	473.02M
Revenue (ttm)	291.81M
Net Income (ttm)	-18.42M
Shares Out	25.57M
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	40.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	4,156
Open	18.55
Previous Close	18.50
Day's Range	18.55 - 18.55
52-Week Range	17.20 - 40.00
Beta	0.87
RSI	35.34
Earnings Date	Apr 17, 2025

About Mentice AB

Mentice AB (publ) provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas. The company operates through three segments: Systems, Software Licenses and Service. It offers software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced, essential, and int...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 132
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2024, Mentice AB's revenue was 291.81 million, an increase of 6.07% compared to the previous year's 275.12 million. Losses were -18.42 million, 553.9% more than in 2023.